GARCIA RUBEN A 4
4 · FibroBiologics, Inc. · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
FibroBiologics (FBLG) GC Ruben Garcia Buys 40,000 Shares
What Happened
- Ruben A. Garcia, General Counsel of FibroBiologics, purchased 40,000 shares of FBLG in open-market transactions on February 27, 2026. The reported weighted average price was $0.33 per share for a total reported value of $13,056. This was a purchase (insider buy), not a sale.
Key Details
- Transaction date: 2026-02-27 (reported on Form 4 filed 2026-03-02)
- Transaction type/code: Open-market purchase (P)
- Price: weighted avg $0.33 per share (total $13,056)
- Price range (footnote): individual trades ranged from $0.3221 to $0.3268 on Feb 27, 2026; the filer can provide per-trade detail on request
- Shares owned after transaction: Not specified in the provided filing
- Filing timeliness: Form 4 filed on Mar 2, 2026 for a Feb 27 trade — appears to be filed within the normal Form 4 reporting window
Context
- Insider purchases can be of interest to retail investors as one data point of insider sentiment, but they do not by themselves indicate a definitive view of company prospects. This filing reports an open-market buy by the company’s general counsel; no options exercise, award, or gift was involved.
Insider Transaction Report
Form 4
GARCIA RUBEN A
General Counsel
Transactions
- Purchase
Common Stock
[F1]2026-02-27$0.33/sh+40,000$13,056→ 180,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3221 to $0.3268 on February 27, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Signature
/s/ Ruben A. Garcia|2026-03-02